advanced solid cancers
Showing 1 - 25 of >10,000
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)
Active, not recruiting
- Metastatic Cancer
- HER2 Gene Mutation
- Neratinib Maleate
-
Seoul, Korea, Republic ofKorea university Guro hospital
Oct 18, 2023
Solid Tumor Trial in Adelaide (Radvax)
Recruiting
- Solid Tumor
- Radvax
-
Adelaide, South Australia, AustraliaARASMI
Apr 8, 2023
Solid Carcinoma Trial (fecal microbiota transplantation with Nivolumab)
Not yet recruiting
- Solid Carcinoma
- fecal microbiota transplantation with Nivolumab
- (no location specified)
Sep 14, 2022
Advanced Solid Cancers Trial in Tainan (ADI PEG20, Pembrolizumab)
Terminated
- Advanced Solid Cancers
- ADI PEG20
- Pembrolizumab
-
Tainan, TaiwanFacility National Cheng Kung University
Apr 20, 2022
Advanced Solid Tumor, Triple Negative Breast Cancer Trial (Pembrolizumab & ADG106 (Phase Ib), Pembrolizumab & ADG106 (Phase II))
Not yet recruiting
- Advanced Solid Tumor
- Triple Negative Breast Cancer
- Pembrolizumab & ADG106 (Phase Ib)
- Pembrolizumab & ADG106 (Phase II)
- (no location specified)
Aug 5, 2022
Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 22, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Biopsy
- +3 more
- (no location specified)
Jan 18, 2023
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory
Completed
- Advanced Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2022
Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory
Withdrawn
- Advanced Malignant Neoplasm
- +10 more
- Brigatinib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2022
Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)
Enrolling by invitation
- Breast Cancer
- +7 more
- e-PRO monitoring
-
Kobe, Hyogo, JapanKobe University Graduate School
Jun 27, 2023
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
-
Boston, Massachusetts
- +5 more
Jan 7, 2023
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Terminated
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
-
Houston, TexasM D Anderson Cancer Center
Dec 22, 2022